Inclusion in Australian Orthopaedic Research
- Apr 6
- 1 min read
Do we really understand who benefits from orthopaedic research in Australia?
Recently, Michael A Schuetz and Richard Page brought together an extraordinary cross-section of the orthopaedic ecosystem to launch the Academy of Orthopaedic Excellence (ACE) in Brisbane. The room reflected the full spectrum of stakeholders — clinicians, researchers, industry, insurers, government, and consumer representatives — all united by a common goal: improving orthopaedic care for Australians.
So why is ACE needed?
Because while Australia produces high-quality orthopaedic research, it remains fragmented. Pathways into research are often unclear, collaboration is inconsistent, and access to resources can be limited.
More importantly, there is a deeper question we must confront — equity.
Orthopaedic surgery, like many specialties, does not yet reflect the diversity of the Australian community. That raises a critical issue: who is our research really serving?
International evidence, particularly from the United States, shows that women and under-represented groups often experience poorer outcomes following orthopaedic procedures. Yet only a minority of studies meaningfully analyse outcomes by gender — and even fewer consider race, identity, or broader determinants of health.
In Australia, organisations like the National Health and Medical Research Council and the Medical Research Future Fund are placing increasing emphasis on equity in research.
However, much of our research funding still comes from industry and private sources, where there is no consistent requirement to assess how outcomes vary across different populations.
If we are serious about improving outcomes, this has to change.
ACE represents an important step forward — creating a more connected, inclusive and purpose-driven research ecosystem.
Delighted to be part of such a thoughtful and forward-looking initiative.
